Related references
Note: Only part of the references are listed.Synthesis and Biological Evaluation of PF-543 Derivative Containing Aliphatic Side Chain
Seon Woong Kim et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges
Mirela Sedic et al.
ANTICANCER RESEARCH (2019)
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
Guangfu Li et al.
GASTROENTEROLOGY (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
A Phase 2 Study of the Sphingosine-1-Phosphate Antibody Sonepcizumab in Patients With Metastatic Renal Cell Carcinoma
Sumanta K. Pal et al.
CANCER (2017)
Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives
Jason P. Cooper et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation
Michael V. Airola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis
Michael J. Pulkoski-Gross et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)
Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death
Saskia Klutzny et al.
CELL DEATH & DISEASE (2017)
Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
Huajie Cai et al.
ONCOLOGY LETTERS (2017)
Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase
Aiping Bai et al.
PLOS ONE (2017)
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D. Britten et al.
CLINICAL CANCER RESEARCH (2017)
Targeting acid sphingomyelinase with anti-angiogenic chemotherapy
Jeanna Jacobi et al.
CELLULAR SIGNALLING (2017)
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Iole Maria Di Gangi et al.
Oncotarget (2016)
Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543
TongFa Ju et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma
Sabrina Krautbauer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma
Georgios Grammatikos et al.
ONCOTARGET (2016)
C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy
Nithin B. Boppana et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2015)
The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo
Heather Venant et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
Yasir Bashir et al.
SOUTH ASIAN JOURNAL OF CANCER (2015)
Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma
Mei-Hong Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs
Aiping Bai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells
Adharsh P. Ponnapakam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
Oleksandr Pastukhov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
A novel liposomal formulation of FTY720 (Fingolimod) for promising enhanced targeted delivery
Yicheng Mao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Effective inhibition of acid and neutral ceramidases by novel B-13 and LCL-464 analogues
Krishna P. Bhabak et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
Nobuyoshi Kosaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1
C. Rutherford et al.
CELL DEATH & DISEASE (2013)
Metabolism, Physiological Role, and Clinical Implications of Sphingolipids in Gastrointestinal Tract
Krzysztof Kurek et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
Yixing Jiang et al.
BIOMOLECULES (2013)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
J. Nunes et al.
BRITISH JOURNAL OF CANCER (2012)
Molecular Targets of FTY720 (Fingolimod)
M. R. Pitman et al.
CURRENT MOLECULAR MEDICINE (2012)
Collateral sensitivity as a strategy against cancer multidrug resistance
Kristen M. Pluchino et al.
DRUG RESISTANCE UPDATES (2012)
Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature
Rao Muralikrishna Adibhatla et al.
NEUROCHEMICAL RESEARCH (2012)
Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
Peng Gao et al.
PLOS ONE (2012)
Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration
Roger A. Sabbadini
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure
Jason P. Cooper et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts
Vladimir Beljanski et al.
CANCER BIOLOGY & THERAPY (2011)
A Phase I Clinical Trial of Safingol in Combination with Cisplatin in Advanced Solid Tumors
Mark A. Dickson et al.
CLINICAL CANCER RESEARCH (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
被撤回的出版物: Antitumor Effects of OSU-2S, a Nonimmunosuppressive Analogue of FTY720, in Hepatocellular Carcinoma (Retracted article. See vol. 76, pg. 1554, 2022)
Hany A. Omar et al.
HEPATOLOGY (2011)
Alteration of Ceramide Synthase 6/C16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network
Can E. Senkal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide
Mehrdad Rahmaniyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Characterization of a Sphingosine 1-Phosphate Receptor Antagonist Prodrug
Perry C. Kennedy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Sphingomyelin Synthases Regulate Protein Trafficking and Secretion
Marimuthu Subathra et al.
PLOS ONE (2011)
Role of reactive oxygen species in the synergistic cytotoxicity of safingol-based combination regimens with conventional chemotherapeutics
Leong-Uung Ling et al.
ONCOLOGY LETTERS (2011)
Potent Inhibition of Acid Ceramidase by Novel B-13 Analogues
Denny Proksch et al.
JOURNAL OF LIPIDS (2011)
FTY720 induces necrotic cell death and autophagy in ovarian cancer cells A protective role of autophagy
Ning Zhang et al.
AUTOPHAGY (2010)
Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity
Jacqueline V. Chapman et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intracellular trafficking of ceramide by ceramide transfer protein
Kentaro Hanada
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway
Jesse Coward et al.
AUTOPHAGY (2009)
Ceramide synthases and ceramide levels are increased in breast cancer tissue
Susanne Schiffmann et al.
CARCINOGENESIS (2009)
Role for sphingosine kinase 1 in colon carcinogenesis
Toshihiko Kawamori et al.
FASEB JOURNAL (2009)
Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer
Ayman E. M. Mahdy et al.
MOLECULAR THERAPY (2009)
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
Steven W. Paugh et al.
BLOOD (2008)
Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels
Leah J. Siskind et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells
David H. Holman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice
F. Dahm et al.
BRITISH JOURNAL OF CANCER (2008)
Sphingolipids and cell death
Albert Morales et al.
APOPTOSIS (2007)
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo
A. Morales et al.
ONCOGENE (2007)
A phase I study of an anti-GD3 monoclonal antibody, KW-2871, in patients with metastatic melanoma
Andres Forero et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2006)
New insights on the use of desipramine as an inhibitor for acid ceramidase
Saeed Elojeimy et al.
FEBS LETTERS (2006)
Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo
Can E. Senkal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells
HJ Kim et al.
ONCOGENE (2006)
Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs
T Granot et al.
LEUKEMIA (2006)
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1
E Bonhoure et al.
LEUKEMIA (2006)
An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission
JL Reynolds et al.
NEUROSCIENCE (2005)
Overcoming resistance to γ-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels
G Alphonse et al.
ONCOGENE (2004)
Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells
AM Meng et al.
EXPERIMENTAL CELL RESEARCH (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
The fate and function of glycosphingolipid glucosylceramide
G van Meer et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2003)
Sphinganine in sphingomyelins of tumors and mouse regenerating liver
EV Dyatlovitskaya et al.
BIOCHEMISTRY-MOSCOW (2001)
The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines
G Merritt et al.
CANCER LETTERS (2001)
Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology
AD Tepper et al.
JOURNAL OF CELL BIOLOGY (2000)
N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells
E Bieberich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
